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Background: Zfp36l2 is critical for female fertility.
Results: N-Zfp36l2 protein shuttles between the cytoplasm and nucleus, binds to RNAs containing AREs, and promotes
deadenylation. N-Zfp36l2 is more resistant to stimulus-induced down-regulation.
Conclusion: N-Zfp36l2 protein is more stable, suggesting the molecular basis of the phenotype.
Significance:Mutation of Zfp36l2 protein results in developmental arrest suggesting that it is critical for regulation of embry-
onic development in mammals.
The zinc finger protein 36-like 2, Zfp36l2, has been impli-
cated in female mouse infertility, because an amino-terminal
truncationmutation (N-Zfp36l2) leads to two-cell stage arrest
of embryos derived from the homozygous mutant female
gamete. Zfp36l2 is a member of the tristetraprolin (TTP) family
of CCCH tandem zinc finger proteins that can bind to tran-
scripts containing AU-rich elements (ARE), resulting in dead-
enylation and destabilization of these transcripts. I show here
that the mouse Zfp36l2 is composed of two exons and a single
intron, encoding a polypeptide of 484 amino acids. I observed
that N-Zfp36l2 protein is similar to both wild-type Zfp36l2
and TTP (Zfp36) in that it shuttles between the cytoplasm and
nucleus, binds to RNAs containing AREs, and promotes dead-
enylation of a model ARE transcript in a cell-based co-transfec-
tion assay. Surprisingly, in contrast to TTP, Zfp36l2 mRNA and
protein were rapidly down-regulated upon LPS exposure in
bone marrow-derived macrophages. The N-Zfp36l2 protein
was substantiallymore resistant to stimulus-induced down-reg-
ulation than the WT. I postulate that the embryonic arrest
linked to the N-Zfp36l2 truncation might be related to its
resistance to stimulus-induced down-regulation.
Zfp36l2 (zinc finger protein 36 like 2), also known as TIS11D
(1), ERF2 (2), and BRF2 (3), is critical for female fertility,
because maternal expression of an amino-terminal truncated
form leads to arrest of early embryonic development at the two-
cell stage (4).
Zfp36l2 belongs to the tristetraprolin (TTP)2 (also known as
ZFP36, TIS11, and GOS24) family of CCCH zinc finger pro-
teins, which contain tandem zinc-binding motifs characterized
by three cysteines followed by one histidine (CCCH) (5). TTP
itself has an anti-inflammatory function, as TTP knock-out
mice display a severe systemic inflammatory syndrome that is
due, in large part, to increased production of tumor necrosis
factor  (TNF) (6, 7).
Another member of this protein family is Zfp36l1, also
known as TIS11B (1), cMG1 (8), Berg36 (9), ERF1 (10), and
BRF1 (11). Disruption of this gene in mice resulted in a lethal
phenotype at approximately embryonic day 11, mainly due to
failure of chorioallantoic fusion (12). Recently, a fourth mem-
ber of this family, Zfp36l3, has been identified; its function is
currently unknown, but its expression seems to be restricted to
the rodent yolk sac and placenta (13, 14). These CCCHproteins
can bind to the 3-untranslated regions (3-UTR) of certain
mRNAs containing class II AU-rich elements (ARE, UUAU-
UUA(U/A)(U/A)) through their zinc fingers. Binding is then
followed by degradation of the target mRNAs (15), ultimately
resulting in decreased levels of translated protein (5).
Insight into one biological role for the third family member,
Zfp36l2, came from a mouse model in which homozygous
mutant females expressing a truncated form of Zfp36l2 (N-
Zfp36l2) lacking the amino-terminal 29 amino acids (29NTD)
exhibited complete infertility (4). These females cycled and
ovulated normally, and their ova could be fertilized; however,
when they were crossed with WT males, their embryos were
able to undergo the initial cleavage step but remained arrested
at the two-cell stage. Because Xenopus Zfp36l2 (XC3H-3) can
bind to and destabilize certain mRNAs in cell-free assays (16),
and embryonic progression beyond the two-cell stage requires
degradation of maternal transcripts coupled to zygotic gene
activation (17–19), I have suggested that Zfp36l2 couldmediate
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the destabilization of specific maternal transcripts in early
embryonic development. Although the precise role played by
the amino terminus of Zfp36l2 remains largely unknown, this
sequence may contain a functional domain that is of critical
importance for the control of early embryonic cell proliferation.
The correct structure of the gene in the mouse has also been
uncertain. Previous findings from the N-Zfp36l2 mutant
model (4) suggested that mouse Zfp36l2 gene contains two
exons, as seen in the human gene (20). However, the only pub-
lished report on the mouse Zfp36l2 gene described a cDNA of
1,200 nucleotides originating from a single exon (1). This would
be similar to the situation seen with Zfp36l3 (13). In this report,
I confirm that the mouse gene, like the human, is composed of
two exons separated by a single intron. I also show that the
N-Zfp36l2 protein appears to be more resistant to lipopoly-
saccharide (LPS)-induced down-regulation than the WT
protein.
MATERIALS AND METHODS
Plasmids—A mouse genomic Zfp36l2 clone (MG-TIS11D)
was obtained as described previously (21). The proposed
3-UTR of the transcript, corresponding to bp 2202–3537 of
GenBankTM RefSeq NM_00100186.2, was generated using
3-rapid amplification of cDNA ends. The full-length cDNA
was constructed by removing exon 1, the single intron, and
the beginning of exon 2 from this genomic clone and replacing
them by an EST clone (GenBankTM accession number
AI327503) that contained a spliced sequence in which exon 1
was fused with the beginning of exon 2, as described (21).
Plasmid CMV.mZfp36l2-HA.tag, encoding the hemaggluti-
nin (HA) tag fused to the carboxyl-terminal end of mouse
Zfp36l2, was constructed by removing a fragment of 120 bp
(SstI-SstI fragment) at the 3 end of the cDNA and replacing it
with an 120-bp PCR product containing an HA sequence in-
frame with the last amino acid of Zfp36l2 followed by a stop
codon and an XbaI site. After sequencing, the Zfp36l2-HA was
excised from the pSK vector and introduced into the KpnI-
XbaI sites of the CMV.BGH3/pBS-modified vector (15).
Similarly, a Zfp36l2 sequence fused with GFP was constructed
as described above, except that the 120-bp fragment was
replaced by a PCR product in which the stop codon was
removed and a PspOMI site was introduced. After the 3 end
was sequenced to confirm the desired mutation, the EcoRI-
PspOMI fragment was excised and introduced in-frame with
GFP in the pEGFP-N1 vector fromClontech. TheN-Zfp36l2-
GFP vector was constructed by PCR primer-overlapping
mutagenesis, in which a KpnI site was created immediately
before the second methionine; after sequencing, the N-
Zfp36l2 insert was introduced as described above into the
pEGFP-N1 vector.
Northern Blot Analysis—Dissected mouse tissues were rap-
idly frozen and pulverized in liquid nitrogen and processed
using the RNeasy kit fromQiagen to extract total cellular RNA,
according to the directions of the manufacturer. RNA samples
(10 g) were separated by electrophoresis in 1.2% agarose/
formaldehyde gels and used for Northern blotting (22). The
nylon membranes were hybridized with 32P-labeled Zfp36l2
probes comprising exon 1, the single intron, or exon 2 as
described (4). Northern blots were analyzed using a Phospho-
rImager Typhoon 8600 and ImageQuant software (GE
Healthcare).
Reverse Transcriptase (RT)-PCR and Real Time RT-PCR—A
total of 1 g of RNA was used to synthesize cDNA using the
High Capacity cDNA archive kit (Applied Biosystems)
according to manufacturer’s instructions. To quantify TTP
and Zfp36l2, 9 ng of cDNA was combined with predesigned
primer/probe sets and TaqMan Universal PCR Master Mix
(Applied Biosystems). For the housekeeping gene, 4 ng of
cDNA was used to detect GAPDH. All reactions were per-
formed in triplicate in 96-well plates. Real time assays were
run on an ABI 7000 sequence detector system (Applied
Biosystems).
In Vitro Translated Zfp36l2 Labeled with 35S—To allow the
linearization of the plasmid at the 3 end using a preferred
restriction enzyme, a pBluescript II SK plasmid was con-
structed containing a T7 promoter at the 5 end preceding the
Zfp36l2 cDNA, followed by a unique restriction enzyme site
(HindIII) downstreamof the 3 end of the stop codon. TheRNA
was transcribed from 1 g of linearized plasmids (Zfp36l2
cDNA digested with HindIII) and used as a template to prepare
in vitro translated 35S-cysteine-labeled Zfp36l2 in a rabbit
reticulocyte lysate system or in wheat germ extract (both from
Promega Biotech). The translated protein labeled with 35S-cys-
teine was loaded onto a 10% SDS-polyacrylamide gel and sub-
jected to electrophoresis; the gel was then fixed and incubated
with Autofluor (National Diagnostics), dried, and exposed to
film.
Cell Culture, Transfections, and Protein Extracts—Primary
embryonic fibroblasts were prepared from embryonic day
14–15 mouse embryos, and bone marrow-derived macro-
phages (BMM)were prepared from adult mice as described (7).
Marrow cells were flushed from femurs of individual animals
(2–5-month-old WT and N-Zfp36l2 mice) and cultured in
standardmedium containing colony-stimulating factor for 3–4
weeks. Animal care procedures were in accordance with insti-
tution guidelines for animal use at NIEHS (National Institutes
of Health) and University of North Carolina.
Mouse RAW264.7 cells (AmericanTypeCulture Collection)
were cultured in Eagle’s minimum essential medium with 10%
fetal bovine serum, penicillin (100 units/ml), and streptomycin
(100 g/ml) and treated with lipopolysaccharide (LPS) (1
g/ml, Sigma) for various times in four independent experi-
ments. Finally, RAW cells were pretreated with 50 M cyclo-
heximide (Sigma) for 15 min to inhibit protein synthesis before
LPS stimulation.
HEK 293 cells (American Type Culture Collection) were
maintained in minimum essential medium supplemented with
10% fetal bovine serum, penicillin (100 units/ml), and strepto-
mycin (100 g/ml). Transient transfection of 1  106 cells with
different Zfp36l2 constructs in calcium-phosphate precipitates
was performed as described previously (15). The transfection
mixture was allowed to stay on the cells for 20 h and then
removed; after a further 24-h incubation period, cells were
lysed for protein extraction.
Cytosolic protein extracts from cell lines, primary cells, and
HEK 293 cells transfected with different constructs were pre-
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pared in a buffer solution comprised of 50mM -glycerol phos-
phate (pH 8.2), 0.25 mM sucrose, 1 mM EDTA, 1 mM EGTA, 1
mM DTT, 50 mM sodium fluoride, and 10 mM benzamidine-
HCl, plus the following protease inhibitors: 0.5 mM phenyl-
methylsulfonyl fluoride (PMSF), 2 M pepstatin, 2 M leupep-
tin, and 2 g/ml aprotinin. The amount of protein was
measured using a Bio-Rad assay.
Cell Labeling and Immunoprecipitation—Cell labeling and
immunoprecipitation protocols have been described in detail
elsewhere (6). Briefly, confluent 100- or 60-mm plates of cells
were serum-deprived overnight in DMEM (Invitrogen) supple-
mented with 1% bovine serum albumin (BSA), then preincu-
bated for 1 h in phosphorus-free DMEM without BSA, and
stimulated with 10% (v/v) dialyzed FCS in the presence of
[32P]orthophosphoric acid (0.2 mCi/ml) for 2 h. Next, the cells
were briefly sonicated in a lysis buffer containing 50 mM Tris
(pH 8.3), 0.10 M NaCl, 0.05 M NaF, 5 mM EDTA, 1% (w/v) Non-
idet P-40, and protease inhibitors. Protein extracts were sub-
jected to immunoprecipitation using protein A-Sepharose
beads and a polyclonal peptide antiserum,N2-Zfp36l2-AS. Pre-
cipitated proteins were eluted from the beads, boiled in 4
loading buffer, and separated on 10% SDS-polyacrylamide gels,
which were dried and used for autoradiography.
Zfp36l2 Antisera and Western Blot Analysis—Four to 25 g
of protein extracts fromHEK 293 cells overexpressing Zfp36l2,
or 400–500 g of protein extracts containing endogenous
Zfp36l2, were mixed with a 4 SDS loading buffer, boiled, and
then loaded onto 10 or 8% SDS-polyacrylamide gels. Western
blots were performed using standard techniques. The nitrocel-
lulose membranes were blocked with 5% nonfat milk in Tris-
buffered saline containing 0.5%Tween 20 and then probedwith
different rabbit antisera generated against synthetic peptides.
Two amino- and two carboxyl-terminal peptides, for a total of
four, were synthesized based on the Zfp36l2 protein sequence
(Fig. 1B). Each of the four peptideswere individually conjugated
with keyhole limpet hemocyanin as a protein carrier and then
injected into two different rabbits to produce a total of eight
different rabbit antisera. Among the four peptides, three were
unique to Zfp36l2 amino acid sequences and one was shared
with another family member, Zfp36l1. The extreme amino-ter-
minal peptide, corresponding to amino acids 5–16 translated
from exon 1 (LLSPFYDIDFLC), was named N1-Zfp36l2-AS.
The other amino-terminal sequence was located after the sec-
ond methionine in the beginning of exon 2, corresponding to
amino acids 58–80 (ASNLHALAHPVPSPGSCSPKFPG,
N2-Zfp36l2-AS). The Zfp36l2 carboxyl-terminal specific anti-
serumwas raised using a peptide corresponding to amino acids
423–437 (PAPPSPPFGFQLPRR, C1-Zfp36l2-AS); the fourth,
an extreme carboxyl-terminal sequence shared between
Zfp36l2 and Zfp36l1 and corresponding to amino acids 469–
484 (RRLPIFSRLSISDD) of mouse Zfp36l2, was used to raise a
common carboxyl-terminal antiserum (C2-Zfp36l2-AS). Each
primary antibody was used diluted to 1:10,000 or 1:2,500 for
overexpressed or endogenous protein samples, respectively.
Incubation of the membranes with the secondary goat anti-
rabbit IgG HRP-conjugated (Bio-Rad) was diluted 1:25,000 or
1:50,000 and developed with a SuperSignal West Pico Chemi-
luminescent Substrate (Pierce) according to themanufacturer’s
instructions.
RNA Electrophoretic Mobility Shift Assay—Protein extracts
prepared from HEK 293 cells transfected with either vector
alone (BS), Zfp36l2, or Zfp36l2-HA constructs driven by the
CMV promoter were incubated with 2  105 cpm of a mTNF-
ARE RNA probe (based on bp 1309–1332 of GenBankTM
accession number X02611), at room temperature for 20 min in
20l of lyses buffer (without a protease inhibitor). Heparin and
yeast tRNAwere added to final concentrations of 0.5g/l and
50 ng/liter, respectively, for an additional 10min. The RNA not
associatedwith proteinwas digestedwith 100 units of RNaseT1
(Invitrogen) for 20 min at room temperature. The resultant
reaction mixture was then loaded onto a 6% nondenaturing
acrylamide gel and subjected to electrophoresis at 250 V for 90
min in 0.4 Tris borate/EDTA buffer (15). For the gel super-
shift assay, an HA antibody (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) or the N2-Zfp36l2 antiserumwas added to the
first incubation step together with the protein extract and the
labeled probe for 20min at room temperature. For the assays of
Zfp36l2 in vitro translated using wheat germ extracts, a human
TNF-ARE RNA probe (1331–1389 bp of NM_000594.2) was
used.
Cell-free Deadenylation of Polyadenylated ARE-containing
Probes—Assay andRNAprobes have been described previously
(23). Briefly, all three probes, ARE-A50, ARE, and V, contained
the same 5 sequences. Probe ARE-A50 consisted of 58 bases
transcribed from the multiple cloning sites of the SK vector,
plus 24 bases of the core ARE from the mouse TNF mRNA,
followed by 50 adenosines. Probe ARE was identical to ARE-
A50 except that it did not contain a poly(A) tail. Probe V (vec-
tor) consisted only of 58 bases transcribed from the multiple
cloning sites of SK, but no ARE or poly(A) tail. All plasmids
were linearized andused as templates in the Promega riboprobe
in vitro transcription system. The capped RNA probes were
transcribed in the presence of [-32P]UTP (800 Ci/mmol) and
Ribo m7G cap analog (Promega), and the resulting products
were separated from free nucleotides on G-50 columns. The
reaction mixtures were assembled on ice, and the reaction was
started by adding 50l of probe (4 104 cpm) to 5g of protein
extracts in 50 l in an assay buffer (1 mM HEPES (pH 7.6), 40
mM KCl, and 5% glycerol). The mixtures were incubated on ice
or at 37 °C for 60 min. EDTA at a final concentration of 20 mM
was added to terminate the reaction. The final reactionmixture
was then extracted once with phenol/chloroform. An aliquot of
60 l of the aqueous phase was mixed with 60 l of formamide
stop solution (95% formamide, 0.05% bromphenol blue, 0.1%
xylene cyanol) and then heated at 70 °C for 5 min. Aliquots of
reaction products were analyzed on an 8% acrylamide gel con-
taining 7 M urea.
Fluorescence Microscopy—To observe the subcellular local-
ization of Zfp36l2-GFP and N-Zfp36l2-GFP fusion proteins,
HEK 293 cells (4  104/ml) were plated in two-well (4 cm2)
LabTek glass chamber slides (Nagle Nunc International) and
transfected using calcium phosphate precipitation as described
previously (16), except for the amount of DNA, 1–10 ng per
well of different GFP fusion constructs. The transfection mix-
ture was allowed to stay on the cells for 16 h, and 1–8 h after the
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removal of the transfection mixture, the cells were rinsed twice
at room temperature in PBS, fixed for 10 min in 4% (v/v) para-
formaldehyde, and then rinsed againwith PBS beforemounting
with ProLong Anti-fade (Molecular Probes, Inc., Eugene, OR).
Slides were dried and examined, and images were obtained
using a Zeiss LSM510 confocal microscope (Zeiss, Thornwood,
NY).
RESULTS
Mouse Zfp36l2 Gene and Its Transcript—Analysis of the
mouse genome shows that mouse Zfp36l2 contains two exons,
as does the human gene (20), and encodes a 484-amino acid
protein (Fig. 1A, panel I). The initial description of mouse
Zfp36l2 was from a 1,200-bp cDNA originating from a single
exon, resulting in a predicted protein of 367 amino acids; and
this protein has been used in other studies (24, 25). This cDNA
lacked the coding sequence for 29 and 88 amino acids at the
amino- and carboxyl-terminal ends, respectively.
I usedNorthern blot experimentswith probes corresponding
to exon 1, exon 2, and the 3-UTR to characterize the WT and
mutant transcripts. In the N-Zfp36l2 mutant animals the
small exon 1 was knocked out (Fig. 2A) resulting in a truncated
protein of 455 amino acids (Fig. 1A, panel II). Cytosolic RNA
from WT mouse bone marrow-derived macrophages failed to
hybridize with a probe to the intron sequence (Fig. 2B), because
this sequence is spliced out in the mature Zfp36l2 transcript.
However, the transcript present in the N-Zfp36l2 mice did
hybridize to the intron probe (Fig. 2B) demonstrating that a
portion of the original intron sequence is part of the 5-UTR of
the mutant transcript. Using 3-rapid amplification of cDNA
ends, I obtained the entire 3-UTR, which contains only one
typical polyadenylation signal (AATAAA) located 1810 bp
downstream of the stop codon, in both the WT and mutant
transcript (Fig. 1A).
I next examined the expression of the transcript in tissues
and found a single 3.6-kb Zfp36l2 transcript (Fig. 2C), consis-
tent with the gene model in Fig. 1A. High levels of expression
were observed in typical lymphoid tissues such as thymus,
spleen, small and large intestines, and Peyer’s patches and with
low levels of expression in brain, liver, testis, skeletal muscle,
heart, and kidney. The gel was stained with acridine orange
before transferring to the nylonmembrane to check the loading
amount of RNA per lane (Fig. 2C, lower panel). Interestingly,
Zfp36l2 is highly expressed in oocytes (Fig. 2D) during embryo
development (26) and in female reproductive organs (4, 26).
These data demonstrated that only specific tissues expressed
abundant levels of Zfp36l2 mRNA; among these, mouse
oocytes showed a 7-fold increase when compared with bone
marrow-derived macrophages (Fig. 2D).
Thus, mouse full-length protein is 484 amino acids long,
whereas the mutant protein is 455 amino acids, i.e. 30 amino
acids shorter and likely uses the only methionine in exon 2,
located at amino acid 30 of the wild-type gene. The identity of
these proteins was confirmed by the antibody experiments
described below.
Immunochemical Characterization of Mouse Zfp36l2—HEK
293 cells, which do not express ZFP36 family members, were
transfected with mTTP, mZfp36l1, and mZfp36l2 constructs.
These protein extracts were used to characterize a panel of
Zfp36l2 antisera (Fig. 3, A–D). After an initial characterization
of these antibodies, they were then used to define the nature of
WT and mutant Zfp36l2 proteins. I used anti-peptide antibod-
ies directed at amino- and carboxyl-terminal sequences, as well
as two internal sequences of Zfp36l2 (Fig. 1B). A mixture of
preimmune sera (Fig. 3D) was used as control at a 5-fold greater
concentration than the Zfp36l2-specific peptide antisera. They
FIGURE 1. A, schematic structure of the mouse and human ZFP36L2 genes.
Panel I, mouse Zfp36l2 gene is composed of two exons encoding a polypep-
tide of 484 amino acids (aa), in which 17 amino acids are contributed by the
first exon (blue rectangle) and 467 amino acids by the second exon (pink rec-
tangle). The single intron (400 bp) is spliced in the WT transcript (angled
lines). The mouse transcript has five typical ATTTA elements (vertical bars) and
a single poly(A) signal sequence AATAAA (small rectangle) at the 3-untrans-
lated region (3-UTR). Panel II, N-Zfp36l2 transcript contains the second
exon fused with part of the single intron (horizontal line at the 5-UTR). The
only in-frame ATG, located at the beginning of exon 2, is the translation start
site resulting in a 455-amino acid polypeptide, lacking 29 amino-terminal
amino acids, shown as N (line with double-headed arrows). Panel III, human
gene, ZFP36L2, is also composed of two exons, encoding a polypeptide of 494
amino acids. The human 3-UTR has four ATTTA elements (vertical bars) and
one poly(A) signal sequence (small rectangle). B, amino acid sequences com-
posing the full-length of mouse Zfp36l2 aligned with human and Xenopus
(XC3H-3) ortholog sequences. The tandem CCCH zinc finger domain (line with
dots) that characterizes this small family of proteins is located at the central
part of the linear sequence. The second exon and its only methionine are
indicated by a blue and red arrow, respectively. The blue lines illustrate the
localization of each peptide sequence used to raise different antisera against
the mouse protein.
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did not react with any of the transfected TTP family member
proteins (Fig. 3D).
The amino-terminal antibody (N1-Zfp36l2-AS), directed
against the sequence encoded by exon 1, reacted with a band of
about 60 kDa in protein extracts fromHEK293 cells transfected
with a construct for the full-length Zfp36l2 (Fig. 3A, lane 2).
This antiserum is specific for Zfp36l2, as it failed to react
with transfectants for the empty vector (Fig. 3A, lane 1) and
other TTP family members (Fig. 3A, lanes 4 and 5) or with
N-Zfp36l2 (Fig. 3A, lane 3). Importantly, N1-Zfp36l2-AS
reacted with the endogenous wild-type protein of the same
approximate 58 kDa in macrophage cell extracts from WT
(arrow) but not from N-Zfp36l2 homozygous mice (Fig. 3E,
left panel), confirming that the endogenous mouse Zfp36l2
protein encodes an amino-terminal sequence originated
from exon 1.
The carboxyl-terminal peptide antiserum (C2-Zfp36l2-AS)
reacted with transfected and expressed N-Zfp36l2 and
Zfp36l2 (Fig. 3B, lanes 2 and 3) as well as with mouse Zfp36l1
(Fig. 3B, lane 5), in which the last 14 carboxyl-terminal amino
acids are identical to those of Zfp36l2. This antiserum did not
react with mouse TTP (Fig. 3B, lane 4) or mock-transfected
cells (Fig. 3B, lane 1). It detected both the endogenouswild-type
Zfp36l2 protein and the amino-terminal truncated protein
present in mouse macrophages fromWT and mutant animals,
respectively (Fig. 3E, right panel). This antibody also cross-re-
acted with Zfp36l3, a 100-kDa protein, expressed exclusively in
murine placenta (13). The antiserum C1-Zfp36l2-AS, raised
against a peptide with a sequence unique to Zfp36l2, upstream
of its extreme carboxyl terminus (Fig. 1B) reacted with trans-
fected and expressed Zfp36l2 and N-Zfp36l2 (Fig. 3C, lanes 2
and 3) but not with other TTP family members (Fig. 3C, lanes 4
and 5). This antibody failed to recognize the endogenous pro-
tein in Western blots (data not shown).
The antiserum N2-Zfp36l2-AS raised against a peptide with
a sequence encoded by the beginning of exon 2 (Fig. 1B) reacted
FIGURE 2. Wild-type (WT) and N-Zfp36l2 (Mut) mouse transcripts. A, total RNA (10 g per lane) was isolated from mouse embryonic fibroblasts from WT
and mutant mice, subjected to Northern blot analysis, and probed with exon 1, exon 2, and 3-UTR probes. The upper band corresponds to Zfp36l2 and the
lower band to the N-Zfp36l2 transcript (arrows). B, cytosolic RNA (10 g per lane) was extracted from mouse embryonic fibroblasts, subjected to Northern blot
analysis, and probed with an intron and Neo probes. The new N-transcript hybridized with an intron probe (arrow, left panel) and is not fused with the Neo
mRNA (arrow, right panel). C, Zfp36l2 mRNA is ubiquitously expressed in mouse tissues. Total cellular RNA was isolated from the indicated tissues of adult
C57BL6 mice and subjected to Northern blot analysis. Each lane contains 10 g of total RNA probed with an exon 1 probe. The Zfp36l2 transcript migrates as
a single band of 3.6 kb, and molecular sizes of the 28 S and 18 S ribosomal subunits are shown. The agarose gel was stained with acridine orange showing
similar RNA loading in all lanes. D, Zfp36l2 expression in oocytes. Total RNA was extracted from mouse denuded oocytes, in three independent experiments,
and compared with primary bone marrow macrophages. The samples were subjected to reverse transcription (RT-PCR) and real time PCR to quantify Zfp36l2
expression in oocytes relatively to macrophages; Gapdh was used as housekeeping gene.
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with overexpressedZfp36l2 (Fig. 3F, lane 2, left panel) but failed
to recognize the endogenous protein inWestern blots (data not
shown). Nevertheless, N2-Zfp36l2-AS was effective in immu-
noprecipitating and supershifting the Zfp36l2 protein. The
N2-Zfp36l2-AS immunoprecipitated Zfp36l2 in a dose-depen-
dent manner (Fig. 3G, lanes 2–4) and displayed specificity (Fig.
3H, lane 8), as it did not IPmouseTTPorZfp36l1 (Fig. 3H, lanes
2 and 5). TTP is known to be a phosphoprotein (27, 28), so I
used 32P-labeling to show that N2-Zfp36l2-AS could also
immunoprecipitate endogenous Zfp36l2 from mouse embry-
onic fibroblasts and BMM (Fig. 3I, two left panels), and this
interaction was inhibited by the competing immunogenic pep-
tide (Fig. 3I, two right panels).
N-Zfp36l2 Binds to and Promotes Deadenylation of an ARE
Probe—Next, I evaluated the interaction of the truncated pro-
tein, N-Zfp36l2, with an ARE-containing RNA probe derived
from the mouse TNF sequence (15). It was shown earlier that
theXenopus ortholog of Zfp36l2, XC3H-3, can bind to an ARE-
RNA probe in a mobility shift assay (16). Although overall the
Xenopus protein differs from the mouse protein by 39% (Fig.
1B), the RNA binding domain (amino acids 132–202) is 90%
identical, suggesting that they would bind similarly to mRNAs.
Three lines of evidence demonstrate that the Zfp36l2 protein
binds AU-rich RNAs. First, increasing amounts of mouse
Zfp36l2 protein resulted in a proportional increase of RNA-
protein complex formation (Fig. 4A, lanes 3–5), suggesting that
Zfp36l2 is part of the RNA binding complex, similar to the
original findings with TTP (15). Extracts from HEK 293 cells
transfected with the empty vector resulted in two complexes
(Fig. 4A, lane 2), likely due to endogenous ARE-binding pro-
teins present in this cell (C1 and C2). Note that the complexes
C1 and C2 migrated faster than the Zfp36l2-ARE probe com-
plex (Fig. 4A) and that the TTP family members are not endog-
enously expressed in the HEK 293 cells. Two results demon-
strate that this mobility shift was due to Zfp36l2 binding to the
ARE probe. First, anti-HA antibodies shifted the migration of
the Zfp36l2-HA fusion protein-ARE complex (Fig. 4B, lanes 4
and 5) as did the N2 antibody to the Zfp36l2 protein (Fig. 4C,
lane 5, upper arrow). Second, immunodepletion of Zfp36l2-HA
with either HA antibody (Fig. 4D, lanes 6 and 7) or the N2
antibody to the Zfp36l2 (lanes 8 and 9) abolished the binding of
Zfp36l2 to ARE-RNA (Fig. 4D, lanes 6–9, SS). Thus, as
expected, full-length mouse Zfp36l2 can bind ARE-containing
mRNA probes.
In addition, I didRNAbinding assays using in vitro translated
Zfp36l2 protein from the heterologous wheat germ system.
This resulted in a shift of the humanTNF-ARE probe in a dose-
dependent manner (Fig. 4E, lanes 2–4), which was clearly dis-
tinct from the endogenous proteins in the wheat germ that
FIGURE 3. Immunoreactivity and specificity of each antiserum for
Zfp36l2. Western blot analysis using protein extracts from HEK 293 cells
transfected with empty vector (lane 1) or each member of mTTP family as
follows: full-length Zfp36l2 (lane 2), N-Zfp36l2 starting at the second methi-
onine (lane 3), TTP (lane 4), and Zfp36l1 (lane 5) are shown in A–D. Protein
extracts were prepared as described under “Material and Methods.” A,
N1-Zfp36l2-AS recognizes only full-length Zfp36l2 (lane 2) but not N-, TTP,
or Zfp36l1, lanes 3–5, respectively. B, C2-Zfp36l2-AS detects both versions of
Zfp36l2 protein (lanes 2 and 3) and Zfp36l1 (lane 5). C, C1-Zfp36l2-AS recog-
nized different versions of Zfp36l2 (lanes 2 and 3) but not TTP or Zfp36l1 (lanes
4 and 5, respectively). D, preimmune serum does not immunoreact with any
CCCH family member. E, Western blot analysis using protein extracts from
BMM of WT and mutant (Mut) mice were prepared as described under “Mate-
rial and Methods.” N1-Zfp36l2-AS recognized the WT endogenous protein
but not the mutant present in the N-Zfp36l2 mouse (arrow, left panel).
C2-Zfp36l2-AS immunoreacted with WT and N-Zfp36l2 proteins (right
panel), and nonspecific bands are indicated by small arrows. F, N2-Zfp36l2-AS
detected an 60-kDa band in protein extracts from overexpressed Zfp36l2
(lane 2) but not with the empty vector (lane 1). This band recognition was
blocked by the competing peptide (pep) () (right panel), and nonspecific
bands are indicated by small arrows. G, N2-Zfp36l2-AS immunoprecipitated in
vitro translated Zfp36l2. Zfp36l2 translated in vitro, using a rabbit reticulocyte
system, and labeled with 35S was immunoprecipitated in a dose-dependent
manner (arrow). Lanes 1– 4 show products containing the same amount of in
vitro translated Zfp36l2 protein incubated either with preimmune serum
(lane 1) or with decreasing amounts of the antiserum: 1:50, 1:100, or 1:500,
lanes 2– 4, respectively. As a negative control (lane 5), in vitro translated pro-
tein that did not contain exogenous Zfp36l2 mRNA was subjected to IP with
the antiserum in a dilution of 1:100. As a positive control, a small amount of
crude protein extract (not IP) containing mRNA of Zfp36l2 was loaded in lane
6. H, N2-Zfp36l2-AS immunoprecipitated Zfp36l2 but not the other two fam-
ily members, TTP or Zfp36l1. A small amount of total in vitro translated protein
(not IP) from the rabbit reticulocyte system containing TTP, Zfp36l1, and
Zfp36l2 was loaded in lanes 3, 6, and 9, respectively. A fixed dilution (1:50) of
the antiserum (lanes 2, 5, and 8) or preimmune serum (lanes 1, 4, and 7) was
used to immunoprecipitate TTP, Zfp36l1, or Zfp36l2, respectively. A negative
control, similar to the one in lane 5 of the upper panel, was loaded into lane 10.
The numbers on the left side of the figures are numeric values for molecular
mass controls expressed in kDa. I, N2-Zfp36l2-AS immunoprecipitated
endogenous and overexpressed Zfp36l2 protein. Primary cell lines of mouse
embryonic fibroblasts (MEF) and BMM or the HEK 293 cells transfected with
Zfp36l2 construct were labeled in vivo with 32P as described under “Materials
and Methods” and subjected to immunoprecipitation with preimmune
serum (PI) or N2-Zfp36l2-AS antiserum (AS). N2-Zfp36l2-AS (arrow), but not
preimmune serum, was able to immunoprecipitate endogenous (three left
panels) and overexpressed Zfp36l2 (right panel). The amount of immunopre-
cipitated material was reduced by a third of the original amount in the pres-
ence of the competing peptide (), two right panels.
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bound the AU-rich probe (Fig. 4E, lane 1). Note that the inten-
sity of C1 and C2 complexes varies according to the volume of
WGSused in reaction. Expression of recombinant Zfp36l2 pro-
tein from WGS was confirmed by autoradiography (Fig. 4F).
This result, obtained using a heterologous system, excludes the
possibility that intermediate proteins in the extract are required
for the RNA binding. The recombinant purified protein would
have been the preferable way to address “direct binding” of
Zfp36l2 to RNA. However, it has not been possible to express
this protein or other CCCH family members as recombinant
proteins able to actively bind to RNA.
I next compared the effects of the full-length Zfp36l2 and
N-Zfp36l2 truncation in three assays: binding to ARE-con-
taining RNA probes in a gel-shift assay, stimulated deadenyla-
tion of ARE-containing polyadenylated RNA probes in a cell-
free assay, and deadenylation of a modified ARE transcript in
cell extracts. The N-Zfp36l2-GFP protein bound to the ARE-
RNA probe in a manner similar to WT-Zfp36l2-GFP, as
assessed by gel-shift assays (Fig. 5A). Both proteins shifted the
ARE probe to similar region of the gel and with similar intensi-
ties (Fig. 5A, lanes 2 and 3). N-Zfp36l2-GFP also stimulated
the deadenylation of an ARE-containing polyadenylated RNA
probe to approximately the same extent as either TTP-GFP or
WT-Zfp36l2 in this cell-free assay (Fig. 5B, lanes 5, 8, and 9).
Likewise, N-Zfp36l2 was as effective as WT-Zfp36l2 in pro-
moting deadenylation of a transfected TNF reporter mRNA
(15) in intact cells (Fig. 5C). The protein extracts used in Fig. 5,
A and B, displayed comparable levels of expression of the
Zfp36l2 WT and truncated proteins in Western blot (Fig. 5D).
Thus, the N-Zfp36l2 protein is functional with respect to
RNA binding and promotion of RNA deadenylation, like WT
and the other TTP family member proteins.
Amino-terminal Truncation in N-Zfp36l2 Does Not Alter
Subcellular Localization—Alteration in the subcellular distri-
bution of N-Zfp36l2 could explain the arrest of the
N-Zfp36l2 embryos at the two-cell stage. To test whether
there was a difference in the subcellular localization of the
truncated protein, HEK 293 cells were transfected with
WT-Zfp36l2-GFP and N-Zfp36l2-GFP plasmids; extracts
from the transfected cells were used forWestern blots (Fig. 6A)
and intact cells for confocal microscopy (Fig. 6, B–F). GFP
fusion proteins were chosen because two of the antibodies
N2-Zfp36l2-AS and C1-Zfp36l2-AS failed to work in immuno-
histochemistry staining. One of the best antibodies,
N1-Zfp36l2-AS, could not be used for this purpose because it
recognizes theWTbut does not recognize theN-Zfp36l2 pro-
tein. The most sensitive antiserum, the common carboxyl-ter-
minal antiserum (C2-Zfp36l2-AS), recognizes both Zfp36l2
and Zfp36l1 (Fig. 3A). Therefore, GFP fusion was used as an
alternative to investigate the localization of themutant protein.
Western blots showed no evidence of degradation of the fusion
proteins (Fig. 6A), suggesting that the GFP immunofluores-
cence faithfully represented the characteristics of the fusion
proteins observed by confocal microscopy. N-Zfp36l2-GFP
FIGURE 4. Interaction of Zfp36l2 protein with RNA. RNA electrophoretic
mobility shift assays were done incubating protein extracts from HEK 293
cells transfected with mouse Zfp36l2 or empty vector (V) with 2  105 cpm of
32P-labeled mTNF (1309 –1332 bp) ARE probe. RNA-protein complexes were
resolved in a 6% acrylamide nondenaturing gel. A, increasing amounts of
protein extracts containing overexpressed Zfp36l2 resulted in increased shift
of the probe electrophoretic migration (lanes 3–5, arrow) in regard to the
original probe migration (lane 1, P). Protein extracts from HEK 293 cells trans-
fected with the empty vector (V) result in the formation of two complexes (C1
and C2, double arrows). B, HEK 293 cells were transfected with Zfp36l2-HA
construct. Protein extracts were incubated as described previously, except for
the presence of increasing amounts of HA-antibody (HA-Ab). The HA-Ab
shifted the migration of the Zfp36l2-TNF ARE complex (supershift, SS, lanes
4 and 5). C, N2-Zfp36l2-AS was able to shift the Zfp36l2-HA-TNF ARE com-
plex, in a similar fashion as the HA-Ab (SS, in lane 5). D, immunodepletion of
Zfp36l2 from protein extracts of HEK 293 cells overexpressing Zfp36l2-HA
abolished the shift of TNF probe. The Zfp36l2 protein present in the extracts
of HEK 293 cells transfected with Zfp36l2-HA was incubated with the HA-Ab
(lanes 6 and 7) or with N2-Zfp36l2-AS (lanes 8 and 9 and, then immunoprecipi-
tated using protein A-Sepharose beads. The immunodepleted protein
extracts (lanes 6 –9) were used in the RNA electrophoretic mobility shift
assays. In lanes 6 and 8, the Zfp36l2-immunodepleted extracts were incu-
bated with RNA probe plus HA-Ab, and in lanes 7 and 9 the complexes were
incubated with the N2-Zfp36l2-AS and resolved in a 6% acrylamide nonde-
naturing gel. The ability of these antibodies to shift the protein-TNF-probe
complex was virtually gone in the Zfp36l2-immunodepleted extract (lanes
6 –9, SS). Unspecific recognition was observed in the AS (arrowhead). The
same protein extracts containing Zfp36l2 before the immunodepletion
resulted in a shift (lane 3) or in a supershift in the presence of HA or
N2-Zfp36l2-AS (lanes 4 and 5, SS). E, recombinant Zfp36l2 protein shifted a
human TNF ARE probe. Increasing amounts of recombinant Zfp36l2 (5, 10,
and 15 l, lanes 2– 4, respectively) from a WGS containing Zfp36l2 mRNA
shifted a 32P-labeled human TNF (1331–1389 bp) ARE probe (upper arrow).
As a negative control, 15 l of wheat germ system that did not contain exog-
enous Zfp36l2 mRNA was incubated with TNF ARE probe, and this resulted in
no shift (lane 1). Unspecific complexes, C1 and C2, were present in lanes 1– 4
(lower arrows). Note that the intensity of C1 and C2 complexes varies accord-
ing to the volume of WGS used in reaction. F, expression of recombinant
Zfp36l2 protein from WGS. Recombinant proteins using WGS with or without
exogenous Zfp36l2 mRNA were labeled with 35S, loaded in a 10% SDS-PAGE,
and exposed to film. As a negative control, in vitro translated protein that did
not contain exogenous Zfp36l2 mRNA was loaded in lane 1. Increasing
amounts of recombinant Zfp36l2 protein from WGS were loaded in lanes 2– 4,
respectively.
Mouse Zfp36l2 and N-Zfp36l2 Truncation
13122 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 16 • APRIL 13, 2012
was expressed at levels similar to those of WT-Zfp36l2-GFP in
HEK cells (Fig. 6A, lanes 4 and 3, respectively). The subcellular
localization of expressedN-Zfp36l2-GFP (Fig. 6,D and F) and
WT-Zfp36l2-GFP (Fig. 6, C and E) was indistinguishable; both
proteins displayed a cytoplasmic subcellular pattern (Fig. 6,
C–F). In a previous publication (21), we showed that all three
CCCH zinc finger proteins, TTP, Zfp36l1, and Zfp36l2, shuttle
between the nucleus and the cytoplasm despite being GFP-
tagged, suggesting that theGFP tag does not interferewith their
cytoplasmic subcellular localization or with their shuttling
ability.
Zfp36l2 is a shuttling protein sensitive to leptomycin B,
which selectively inhibits the nuclear export receptor CRM1
(21). Removal of the 29 amino acids at the amino-terminal
sequence of Zfp36l2 did not affect its shuttling properties (data
not shown). Therefore, it is unlikely that the embryo arrest seen
FIGURE 5. RNA functional assays of Zfp36l2 and N-Zfp36l2. A, in a gel
shift assay, protein extracts from HEK 293 cells transfected with GFP (vec-
tor) or Zfp36l2-GFP or N-Zfp36l2-GFP (respectively, lanes 2–3) were incu-
bated with a 32P-mTNF-ARE probe for 20 min at room temperature. The
products were separated on an 8% nondenaturing polyacrylamide gel
followed by autoradiography. Both protein extracts containing Zfp36l2-
GFP or N-Zfp36l2-GFP formed complexes with the labeled RNA probe,
shifting the migration position of the free probe (lane 4, P) to an upper
region (arrow). B, cell-free deadenylation of polyadenylated ARE-contain-
ing probes. Protein extracts of HEK 293 cells transfected with different
constructs, as indicated in the figure, were incubated with 32P-labeled
ARE-A50 RNA probe at 37 °C in the presence () or absence () of EDTA to
inhibit cellular exonucleases for 60 min. The probes were then purified
and subjected to electrophoresis on urea-polyacrylamide gels, followed
by autoradiography. The arrows indicate the migration position of the
polyadenylated probe (ARE-A50), deadenylated product of the probe
(ARE), and empty vector (V), upper, middle and lower arrows, respectively.
C, dose-response effect of WT and N-Zfp36l2. A fixed amount of 1 g of
CMV.mTNF was co-transfected into HEK 293 cells with increasing
amounts of the expression vector Zfp36l2-GFP (left panel) or N-Zfp36l2-
GFP (right panel). Each condition was adjusted to a final concentration of 3
g of transfected DNA by addition of vector alone. Twenty four hours after
the removal of the transfection mixture, total cellular RNA was harvested.
Each lane contains 10 g of total RNA subjected to Northern blot assay
and hybridized sequentially with Zfp36l2, TNF and cyclophilin 32P-la-
beled probes. The upper arrow indicates Zfp36l2 fusion constructs; the
double arrows indicate the two species of TNF mRNA, and the lower arrow
indicates the cyclophilin transcript used to normalize the samples. D,
Western blot analysis and protein quantification; 25 g of protein extracts
from HEK 293 cells co-transfected with 50 ng of BS (vector), GFP,
Zfp36l2-GFP, or N-Zfp36l2-GFP constructs in the presence of 1 g of
CMV.mTNF were probed with a GFP-antibody. The bands were quanti-
fied and plotted in a bar graph.
FIGURE 6. Expression of Zfp36l2-GFP and N-Zfp36l2-GFP. HEK 293 cells
were transfected with GFP or GFP fusion plasmids, and samples were simul-
taneously processed for Western blotting and confocal microscopic analysis.
A, Western blots containing 25 g per lane of cytosolic protein extracts from
transfected HEK 293 cells were probed with an anti-GFP antibody. Each lane
corresponds, respectively, to cells transfected with empty vector (lane 1), GFP
(lane 2), Zfp36l2-GFP (lane 3), and N-Zfp36l2-GFP (lane 4). Note the similar
levels of expression of the WT and N-Zfp36l2 fusion proteins. B, shows a
confocal image of HEK 293 cells expressing GFP alone, and the other panels
show WT-Zfp36l2-GFP (C and E) and N-Zfp36l2-GFP (D and F). Bars represent
10 m.
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in the N-Zfp36l2 mouse is related to an abnormal cellular
localization of N-Zfp36l2 or to an altered nucleus-cytoplas-
mic shuttling property, because they were indistinguishable
from those of the WT protein.
Stimulus-induced Reciprocal Regulation of Zfp36l2 and TTP
mRNAs—Lipopolysaccharide (LPS) is a prototypical inducer of
TTP mRNA, promoting a large increase in its levels within 1 h
inmacrophages andmonocytes (29–31). I thus investigated the
pattern of Zfp36l2 mRNA expression after LPS stimulation in
bonemarrow-derivedmacrophages fromWT and N-Zfp36l2
mice using Northern blot and real time PCR (RT-PCR). Sur-
prisingly, unlike TTP, the Zfp36l2 mRNA was rapidly down-
regulated upon exposure of bone marrow-derived macro-
phages to LPS. After 15 min of LPS exposure, there was a slight
induction (1.5-fold) of Zfp36l2 expression; however, 60 min
after addition of LPS, the levels of Zfp36l2 mRNA were
decreased 4-fold from the basal values (Fig. 7A).
AlthoughN-Zfp36l2mRNA is expressed at lower basal lev-
els than the WT transcript, its response to LPS was similar to
that seen with the WT transcript. The N-Zfp36l2 transcript
was also down-regulated by LPS (Fig. 7A). Similar results were
obtained using RT-PCR (Fig. 7B).
The TTP mRNA expression profile after LPS stimulation of
bonemarrow-derivedmacrophages fromWT and N-Zfp36l2
mice was indistinguishable (Fig. 7B). However, the major dif-
ference between the effects of LPS on the regulation of TTP and
Zfp36l2 mRNAs is illustrated in Fig. 7C. LPS slightly increased
Zfp36l2 mRNA levels, followed by a rapid and marked down-
regulation, whereas TTP mRNA levels are massively induced
followed by a return to base line by 2 h. The LPS-induced down-
regulation of Zfp36l2 mRNA was preceded by a significant
induction of TTPmRNA at 30 min. This time course raises the
interesting possibility that TTPmight be involved in the down-
regulation of Zfp36l2 mRNA levels. However, I found that
down-regulation of Zfp36l2mRNAwas independent of TTP, as
it also occurred in TTP-KO bone marrow-derived macro-
phages after LPS exposure.3
Down-regulation of Zfp36l2, but Not N-Zfp36l2, by LPS—
Toevaluate the effect of LPS onZfp36l2 protein levels, I initially
examined Zfp36l2 protein levels in a mouse macrophage cell
line, RAW 264.7. Unlike TTP (28), Zfp36l2 protein levels
decreased over time after LPS exposure (Fig. 8A), with a half-
maximal decrease seen at about 3 h (Fig. 8, A and C, black
squares).
The effects of LPS on the levels of the WT-Zfp36l2 and
N-Zfp36l2 proteins were evaluated using bone marrow-de-
rivedmacrophages fromwild-type and theN-Zfp36l2mutant
mice, respectively. N-Zfp36l2 protein was resistant to LPS-
induced down-regulation, although the wild-type protein was
down-regulated at a similar rate as in RAW cells (Fig. 8, B and
C). This result suggests that one difference between the wild-
type and mutant protein is that the mutant protein is more
stable than thewild-type protein when cells are stimulatedwith
LPS. Note that there is shift in mobility of both proteins as a
result of LPS treatment.
LPS-induced down-regulation of Zfp36l2 was independent
of protein synthesis, as pretreatment of RAW 264.7 cells with
cycloheximide did not alter the LPS effect on Zfp36l2 levels
(Fig. 8, D and E). Thus, in addition to down-regulation of the
Zfp36l2 mRNA, the protein is rapidly degraded when cells are
stimulated with LPS, although the mutant protein is stable
under these conditions.
DISCUSSION
Here I have demonstrated that the structure of the mouse
Zfp36l2 gene conforms to its human ortholog (20) and encodes
a protein with 89% identity at the amino acid level, which is
highly conserved among different vertebrates (Fig. 1B). Mouse
Zfp36l2 can bind to typical mRNA-containing ARE probes,
although the specific mRNA targets for Zfp36l2 remain
unknown. Zfp36l2-RNA complexes already assembled under
the in vitro conditions were not disrupted by an antibody bind-
ing to the amino or carboxyl terminus (Fig. 4C), suggesting that
the ends of the termini do not interfere with ARE-RNA binding
under these conditions. This result is consistent with previous
findings that removing 96 or 153 amino acids of human TTP
from the amino- and carboxyl-terminal ends, respectively, did
not disrupt its RNA binding (16), as measured by similar assays
used here.
Removal of 29 amino acids from the amino terminus of
Zfp36l2 results in female infertility and in expression of a
shorter protein, N-Zfp36l2, in the homozygous animals (4).
3 S. B. V. Ramos, unpublished data.
FIGURE 7. LPS induced decay of Zfp36l2 transcript. A, BMM from WT and
N-Zfp36l2 mice were stimulated with LPS (1 g/ml) in a time course. Total
cellular RNA was isolated at each time point. Ten g of RNA was loaded per
lane, subjected to Northern blot analysis, and probed with Zfp36l2 exon 2 and
Gapdh 32P-labeled probes (left panel). The relative intensity of Zfp36l2 tran-
script in WT (black squares) and N-Zfp36l2 mice (open squares) was quanti-
fied at each time point and corrected by Gapdh using a PhosphorImager. The
final values were expressed as a percentage of the maximum value, which
occurred at 15 min (right panel). B, BMM from WT (n  3) and N-Zfp36l2 (n 
3) mice were isolated and stimulated with LPS (1 g/ml). Total cellular RNA
was isolated at each time point, converted to cDNA, and analyzed by real time
PCR for Zfp36l2 and TTP expression levels (black and open squares; black and
open circles, respectively). Gapdh was used as housekeeping gene. C, LPS
induction of two CCCH transcripts in bone marrow-derived macrophages.
Data obtained from Northern blot analysis were modeled and plotted
graphically.
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To better understand its mechanism, I compared a number of
biochemical properties of the mutant and wild-type proteins.
The subcellular localization of the two proteins and their ability
to bind RNA and promote deadenylation was alike.
Zfp36l2 has a similar overall structure as TTP, with a central
RNA binding domain; however, its amino- and carboxyl-termi-
nal portions are larger. The amino-terminal region of TTP is
required for deadenylation (32). Removal of the amino-termi-
nal region of TTP (100 amino acids), the prototype of the fam-
ily, results in reduced mRNA decay function, and there is evi-
dence suggesting that this protein domain functions as a
binding platform for mRNA decay enzymes (33). I found that
N-Zfp36l2 binds and promotes deadenylation of ARE-mRNA
similarly toWT-Zfp36l2. Thus, using these assays, the absence
of the 29NTD portion of Zfp36l2 does not affect its RNA bind-
ing properties and its ability to promote deadenylation of
ARE-mRNA in vitro.
The 29NTD is part of the pfam Tis11B_N (Tis11B-like pro-
tein, amino terminus), which is also present in Zfp36l1 and
many other proteins. The 29NTD covers only one-fifth of the
Tis11B_N domain of Zfp36l2, and the deletion results in stabi-
lization of the protein in LPS-stimulated macrophages. The
N-Zfp36l2 mutant does not result in a nonfunctional or
“dead” protein in terms of the classical function of the TTP-like
CCCH zinc finger proteins, because the N-Zfp36l2 protein
can bind and deadenylate ARE-mRNA.
Interestingly, I observed that Zfp36l2 mRNA and protein
were rapidly down-regulated in macrophages upon LPS expo-
sure (Figs. 7C and 8) in contrast to TTP (28, 30, 34). Zfp36l2
protein levels decline with a 3-h half-life after LPS treatment.
Strikingly, N-Zfp36l2 protein levels are not decreased after
LPS treatment, although the mRNA is down-regulated like the
wild type. As a result, the mutant accumulates to much higher
levels than the wild-type protein in LPS-treated macrophages
(Fig. 8B). Thus, the first 29 amino acids are essential for the
degradation of Zfp36l2 under these conditions.
Because N-Zfp36l2 was able to regulate an RNA reporter
containing an AU-rich element (Fig. 5), the finding that the
mutant protein has altered stability in response to signals is
consistent with the expression of this mutant protein resulting
in altered regulation of its mRNA targets in vivo, leading to
infertility. Although the physiological mRNA targets for this
protein remain unknown, my hypothesis is that the Zfp36l2
protein acts to affect the stability of an unknown group of
mRNAs expressed during the oocyte to embryo transition.
Identifying target mRNAs in this system is problematic given
the small amounts of material to which one has access. Altered
regulation of these RNA targets may be the basis for the arrest
of the embryos derived from themutant females at the two-cell
stage. Note that this is the point at which zygotic gene activa-
tion and maternal RNA degradation occur. Recently, in
Caenorhabditis elegans five CCCH zinc finger proteins were
shown to be degraded during early embryogenesis (35). Specif-
ically, degradation of OMA-1, OMA-2, and MEX-5 is required
for normal embryogenesis in C. elegans (36, 37). The decay of
these proteins may be related to the degradation of maternal
mRNAs and/or to zygotic gene activation (38). OMA-1 degra-
dation involves phosphorylation by the DYRK kinase MBK-2
(36). It is possible that N-Zfp36l2 lacks the signal that is
required to target Zfp36l2 to the proteasome, modulating its
degradation.
The biochemical characteristics of Zfp36l2, in conjunction
with its maternal effect during early development, suggest that
it may have a similar role in embryogenesis as the CCCH zinc
finger proteins of C. elegans, which are involved in the fate of
the early blastomere (39–43). Thus, early development is crit-
ically dependent on proper metabolism of maternal mRNAs,
which is mediated by maternal RNA-binding proteins. I specu-
late that the two-cell stage blockage observed in embryos
FIGURE 8. N-Zfp36l2 is not down-regulated by LPS stimulation in BMM
from N-Zfp36l2 mice. A, RAW 264.7 cells were stimulated with LPS (1
g/ml), and protein extracts were prepared at each time point. Sixty g of
cytosolic protein extracts were loaded per lane in a 10% SDS-PAGE. Western
blots were developed using C2-Zfp36l2-AS as described previously. Upper
and lower panels show specific and nonspecific (NS) bands (loading control),
respectively. B, Western blot of LPS (1 g/ml)-stimulated bone marrow-de-
rived macrophages from WT and N-Zfp36l2 animals at different time points
were probed with C2-Zfp36l2-AS (upper panel) or GAPDH antibody (lower
panel). C, Zfp36l2 band at each time point in A and B was quantified using a
National Institutes of Health program. The intensity of Zfp36l2 bands was
corrected by Gapdh or nonspecific bands and plotted (squares, black circles,
and open circles represent the values obtained from RAW, WT, and N-Zfp36l2
cells, respectively). D, Zfp36l2 protein down-regulation was not influenced by
cycloheximide (CHX). Western blot of RAW 264.7 cells stimulated with LPS (1
g/ml) at the indicated time points. The cells were pretreated with vehicle or
cycloheximide (50 M) for 15 min, left and right panel, respectively. E, intensity
of Zfp36l2 and nonspecific (NS) bands were quantified and plotted along the
time course of LPS stimulation in the presence of vehicle (open squares) and
cycloheximide (black squares).
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derived from the N-Zfp36l2mutant females might be associ-
ated with sustained levels of the protein at this early develop-
mental stage.
The 29NTD also contains an unconventional leucine-rich
repeat. In general, leucine-rich repeats are short motifs com-
posed of 20–29 amino acids that provide a structural frame-
work for the formation of protein-protein interactions (44).
Therefore, it is possible that the 29NTD may sense and/or
transduce a yet unknowndevelopmental signal(s), which is crit-
ical for the progression of the embryo beyond the two-cell
stage. Animals lacking the whole Zfp36l2 protein are pan-cyto-
penic; their hematopoietic stem cells seem to be unable to pro-
liferate or differentiate in vivo, suggesting an arrest of these
primordial cells (26). These animals die at an early age, and
hence it is not possible to determine whether they also would
have fertility defects. The wild-type protein likely plays impor-
tant roles in many different tissues, and the mutant protein
must be capable of functioning successfully in these tissues.
Many maternal effect genes display an oocyte-restricted
expression (45–47); Zfp36l2 mRNA is expressed in numerous
but not all mouse tissues, in addition to oocytes. Further under-
standing of the genetic and/or biochemicalmechanisms under-
lying the N-Zfp36l2 mutation is of great interest, because it
leads to complete female infertility inmice, due to a blockage of
the early embryonic development at the two-cell stage. The
targets of this protein that result in developmental arrest are
likely to be critical for regulation of embryonic development in
mammals.
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